Cofetuzumab (Anti-PTK7 / CCK4)

Cofetuzumab (Anti-PTK7 / CCK4) is humanized IgG1 monoclonal antibody against protein tyrosine kinase 7 (PTK7) with potential antitumor activity. MW : 146.7 KD.

• Supplier: Selleck Chemicals
• Product #: A2803
• Sku #: A2803-1mg